Uso de fármacos inmunomoduladores en una consulta de uveítis

De Smet, 2011, Understanding uveitis: the impact of research on visual outcomes, Prog Retin Eye Res., 30, 452, 10.1016/j.preteyeres.2011.06.005 Bloch-Michel, 1987, Am J Ophthalmol., 103, 234, 10.1016/S0002-9394(14)74235-7 Deschenes, 2008, Ocul Immunol Inflamm., 16, 1, 10.1080/09273940801899822 Jabs, 2005, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop, Am J Ophthalmol., 140, 509, 10.1016/j.ajo.2005.03.057 Martínez-Berriotxoa, 2012, Aproximación diagnóstica a las uveítis, Rev Clin Esp., 212, 442, 10.1016/j.rce.2011.12.004 Gritz, 2004, Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study, Ophthalmology., 111, 491, 10.1016/j.ophtha.2003.06.014 Saari, 1995, Epidemiology of endogenous uveitis in south-western Finland, Acta Ophthalmol Scand., 73, 345, 10.1111/j.1600-0420.1995.tb00040.x Nashtaei, 2011, Patterns of uveitis in the Middle East and Europe, J Ophthalmic Vis Res., 6, 233 Durrani, 2004, Uveitis: a potentially blinding disease, Ophthalmologica., 218, 223, 10.1159/000078612 Rothova, 1996, Causes and frequency of blindness in patients with intraocular inflammatory disease, Br J Ophthalmol., 80, 332, 10.1136/bjo.80.4.332 Taylor, 2010, New developments in corticosteroid therapy for uveitis, Ophthalmologica., 224, 46, 10.1159/000318021 Foster, 2016, The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management, Surv Ophthalmol., 61, 1, 10.1016/j.survophthal.2015.07.001 Levy-Clarke, 2014, Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders, Ophthalmology., 121, 785, 10.1016/j.ophtha.2013.09.048 Jabs, 2000, Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel, Am J Ophthalmol., 130, 492, 10.1016/S0002-9394(00)00659-0 Bañares, 1997, Patterns of uveitis as guide in making rheumatologic and immunologic diagnoses, Arthritis Rheum., 40, 358, 10.1002/art.1780400221 Fonollosa, 2011, Uveítis: un abordaje multidisciplinar, Arch Soc Esp Oftalmol., 86, 393, 10.1016/j.oftal.2011.11.001 Jakob, 2009, Uveitis subtypes in a german interdisciplinary uveitis center-analysis of 1916 patients, J Rheumatol., 36, 127, 10.3899/jrheum.080102 Rodriguez, 1996, Referral patterns of uveitis in a tertiary eye care center, Arch Ophthalmol., 114, 593, 10.1001/archopht.1996.01100130585016 Singh, 2004, Pattern of uveitis in a referral eye clinic in north India, Indian J Ophthalmol., 52, 121 Fanlo, 2016, Caracterización de los pacientes con uveítis remitidos a una unidad multidisciplinar de referencia en el norte de España, Arch Soc Esp Oftalmol. Ohguro, 2012, The 2009 prospective multi-center epidemiologic survey of uveitis in Japan, Jpn J Ophthalmol., 56, 432, 10.1007/s10384-012-0158-z Bajwa, 2015, Epidemiology of uveitis in the mid-Atlantic United States, Clin Ophthalmol., 9, 889, 10.2147/OPTH.S80972 Becker, 2005, Management of sight-threatening uveitis: new therapeutic options, Drugs., 65, 497, 10.2165/00003495-200565040-00005 Abásolo, 2016, Immunosuppressive drugs discontinuation in non-infectious uveitis from real life clinical practice: a survival analysis, Am J Ophthalmol., 10.1016/j.ajo.2016.06.007 Prete, 2014, Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center, J Ophthalmic Inflamm Infect., 4, 17, 10.1186/s12348-014-0017-9 Muñoz-Fernández, 2003, Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period, J Rheumatol., 30, 1277 Pasadhika, 2014, Update on the use of systemic biologic agents in the treatment of non-infectious uveitis, Biologics., 8, 67 Barry, 2014, Pharmacotherapy for uveitis: current management and emerging therapy, Clin Ophthalmol., 8, 1891 Joshi, 2014, Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis, Ophthalmology., 121, 1119, 10.1016/j.ophtha.2013.11.032